Yong-Rui Piao , Yang Liu , Chun-Ping Chu , Yu-Zi Li , De-Lai Qiu
{"title":"心房利钠肽受体A的激活通过抑制IH抑制下丘脑PVN crferic神经元的兴奋性。","authors":"Yong-Rui Piao , Yang Liu , Chun-Ping Chu , Yu-Zi Li , De-Lai Qiu","doi":"10.1016/j.neulet.2025.138202","DOIUrl":null,"url":null,"abstract":"<div><div>Atrial natriuretic peptide (ANP) and its receptor are abundantly distributed in hypothalamic paraventricular nucleus (PVN), and contribute to regulation of corticotropin releasing factor (CRF) release in the brain. However, the mechanism by which ANP regulates the activity of PVN CRFergic neurons remains unclear. Here, we investigated the mechanism by which ANP modulates the neuronal activity related to PVN CRF-mRNA expression <em>in vitro</em> in mice using whole-cell patch-clamp recording, single-cell RT-PCR, immunofluorescence, and pharmacological methods. Our data demonstrated that ANP significantly reduced the membrane excitability of PVN neurons expressing CRF-mRNA. This effect was abolished by an antagonist of ANP receptor A (NPR − A), namely A71915. Furthermore, ANP significantly suppressed the hyperpolarization − activated cationic currents (I<sub>h</sub>) of neurons expressing CRF-mRNA. Blockade of either I<sub>h</sub> or NPR − A completely prevented this inhibitory effect. Immunohistochemistry results indicated that NPR − A immunoreactivity was present in PVN CRF-positive neurons. These findings suggest that ANP decreases the excitability of PVN CRFergic neurons via NPR − A − mediated inhibition of I<sub>h</sub> channel activity <em>in vitro</em> in mice.</div></div>","PeriodicalId":19290,"journal":{"name":"Neuroscience Letters","volume":"853 ","pages":"Article 138202"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Activation of atrial natriuretic peptide receptor A depresses hypothalamic PVN CRFergic neuronal excitability by inhibiting IH in vitro in mice\",\"authors\":\"Yong-Rui Piao , Yang Liu , Chun-Ping Chu , Yu-Zi Li , De-Lai Qiu\",\"doi\":\"10.1016/j.neulet.2025.138202\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Atrial natriuretic peptide (ANP) and its receptor are abundantly distributed in hypothalamic paraventricular nucleus (PVN), and contribute to regulation of corticotropin releasing factor (CRF) release in the brain. However, the mechanism by which ANP regulates the activity of PVN CRFergic neurons remains unclear. Here, we investigated the mechanism by which ANP modulates the neuronal activity related to PVN CRF-mRNA expression <em>in vitro</em> in mice using whole-cell patch-clamp recording, single-cell RT-PCR, immunofluorescence, and pharmacological methods. Our data demonstrated that ANP significantly reduced the membrane excitability of PVN neurons expressing CRF-mRNA. This effect was abolished by an antagonist of ANP receptor A (NPR − A), namely A71915. Furthermore, ANP significantly suppressed the hyperpolarization − activated cationic currents (I<sub>h</sub>) of neurons expressing CRF-mRNA. Blockade of either I<sub>h</sub> or NPR − A completely prevented this inhibitory effect. Immunohistochemistry results indicated that NPR − A immunoreactivity was present in PVN CRF-positive neurons. These findings suggest that ANP decreases the excitability of PVN CRFergic neurons via NPR − A − mediated inhibition of I<sub>h</sub> channel activity <em>in vitro</em> in mice.</div></div>\",\"PeriodicalId\":19290,\"journal\":{\"name\":\"Neuroscience Letters\",\"volume\":\"853 \",\"pages\":\"Article 138202\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-03-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroscience Letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0304394025000904\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience Letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304394025000904","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Activation of atrial natriuretic peptide receptor A depresses hypothalamic PVN CRFergic neuronal excitability by inhibiting IH in vitro in mice
Atrial natriuretic peptide (ANP) and its receptor are abundantly distributed in hypothalamic paraventricular nucleus (PVN), and contribute to regulation of corticotropin releasing factor (CRF) release in the brain. However, the mechanism by which ANP regulates the activity of PVN CRFergic neurons remains unclear. Here, we investigated the mechanism by which ANP modulates the neuronal activity related to PVN CRF-mRNA expression in vitro in mice using whole-cell patch-clamp recording, single-cell RT-PCR, immunofluorescence, and pharmacological methods. Our data demonstrated that ANP significantly reduced the membrane excitability of PVN neurons expressing CRF-mRNA. This effect was abolished by an antagonist of ANP receptor A (NPR − A), namely A71915. Furthermore, ANP significantly suppressed the hyperpolarization − activated cationic currents (Ih) of neurons expressing CRF-mRNA. Blockade of either Ih or NPR − A completely prevented this inhibitory effect. Immunohistochemistry results indicated that NPR − A immunoreactivity was present in PVN CRF-positive neurons. These findings suggest that ANP decreases the excitability of PVN CRFergic neurons via NPR − A − mediated inhibition of Ih channel activity in vitro in mice.
期刊介绍:
Neuroscience Letters is devoted to the rapid publication of short, high-quality papers of interest to the broad community of neuroscientists. Only papers which will make a significant addition to the literature in the field will be published. Papers in all areas of neuroscience - molecular, cellular, developmental, systems, behavioral and cognitive, as well as computational - will be considered for publication. Submission of laboratory investigations that shed light on disease mechanisms is encouraged. Special Issues, edited by Guest Editors to cover new and rapidly-moving areas, will include invited mini-reviews. Occasional mini-reviews in especially timely areas will be considered for publication, without invitation, outside of Special Issues; these un-solicited mini-reviews can be submitted without invitation but must be of very high quality. Clinical studies will also be published if they provide new information about organization or actions of the nervous system, or provide new insights into the neurobiology of disease. NSL does not publish case reports.